ACTOLOG Trademark

Trademark Overview


On Wednesday, October 16, 2019, a trademark application was filed for ACTOLOG with the United States Patent and Trademark Office. The USPTO has given the ACTOLOG trademark a serial number of 79275292. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Immatics Biotechnologies GmbH. The ACTOLOG trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and pharmaceutical products, namely, oncological, anti-viral, anti-bacterial and autoimmunity pharmaceuticals and natural remedies; diagnostic reagents for medical purposes; synthetic peptides, binding proteins and living cells for medical, diagnostic and therapeutic purposes, in particular for cancer therapy

Medical services, namely, medical and pharmacological diagnosis of oncological, viral, bacterial, and autoimmune diseases and pharmaceutical services, namely, pharmaceutical compounding services for diagnosis and treatment of oncological, viral, bacterial, and autoimmune diseases; dispensing of pharmaceuticals, namely, providing medical supply for therapy, in particular supply of synthetic peptides, binding proteins and living cells for cancer therapy; medical diagnosis of cancer

Medical research and pharmacological research, namely, pharmaceutical research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistry, biochemistry and biology; scientific laboratory services, namely, biological, biochemical and chemical laboratory services; biological, biochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory services, namely, biological and biochemical laboratory services; biological and biochemical examination services of specimens in the field of cancer treatment and diagnosis
actolog

General Information


Serial Number79275292
Word MarkACTOLOG
Filing DateWednesday, October 16, 2019
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253445
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesMedical and pharmaceutical products, namely, oncological, anti-viral, anti-bacterial and autoimmunity pharmaceuticals and natural remedies; diagnostic reagents for medical purposes; synthetic peptides, binding proteins and living cells for medical, diagnostic and therapeutic purposes, in particular for cancer therapy
Goods and ServicesMedical services, namely, medical and pharmacological diagnosis of oncological, viral, bacterial, and autoimmune diseases and pharmaceutical services, namely, pharmaceutical compounding services for diagnosis and treatment of oncological, viral, bacterial, and autoimmune diseases; dispensing of pharmaceuticals, namely, providing medical supply for therapy, in particular supply of synthetic peptides, binding proteins and living cells for cancer therapy; medical diagnosis of cancer
Goods and ServicesMedical research and pharmacological research, namely, pharmaceutical research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistry, biochemistry and biology; scientific laboratory services, namely, biological, biochemical and chemical laboratory services; biological, biochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory services, namely, biological and biochemical laboratory services; biological and biochemical examination services of specimens in the field of cancer treatment and diagnosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmatics Biotechnologies GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameImmatics Biotechnologies GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameImmatics Biotechnologies GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, November 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 7, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, May 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 29, 2021FINAL DISPOSITION PROCESSED
Monday, April 26, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, December 12, 2020NOTIFICATION PROCESSED BY IB
Wednesday, November 25, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, October 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 21, 2020REFUSAL PROCESSED BY IB
Monday, March 2, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 2, 2020REFUSAL PROCESSED BY MPU
Thursday, February 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 26, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 25, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, January 31, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 30, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 22, 2020ASSIGNED TO EXAMINER
Saturday, January 11, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, January 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB